3-iodobenzylguanidine has been researched along with AL Amyloidosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnulf, B; Baudet, M; Cescau, A; Cohen-Solal, A; Harel, S; Logeart, D; Nicol, M; Royer, B; Sarda-Mantel, L | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and AL Amyloidosis
| Article | Year |
|---|---|
Prognostic Value of Iodine-123-Metaiodobenzylguanidine Scintigraphy in Light-Chain Amyloidosis.
Topics: 3-Iodobenzylguanidine; Aged; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Follow-Up Studies; France; Humans; Immunoglobulin Light-chain Amyloidosis; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Perfusion Imaging; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate | 2019 |